Moderna
Washington (AFP) - Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer. Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020. "We think that in some countries the product could be launched under accelerated approval by 2025," he said in an interview. Unlike conventional vaccines, so-called therapeutic vaccines treat rather than prevent a disease. But they also work by training ...
AFP
Washington (AFP) - US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine. Moderna's experimental mRNA-1010 flu shot is "quadrivalent," meaning it targets four strains of flu: A/H1N1, A/H3N2, B/Yamagata and B/Victoria -- selected based on recommendations by the World Health Organization (WHO). The Massachusetts-based company said that its flu shot generated an immune response against influenza A strains that was equal or superior to that of already licensed vaccines. Howev...
AFP
Washington (AFP) - Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. The lawsuits set up a high-stakes showdown between the leading manufacturers of Covid-19 shots that are a key tool in the fight against the disease. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said in a statement....
AFP
Washington (AFP) - Moderna on Wednesday said its new Covid booster candidate, which it is hoping to get approved this fall, performed well against Omicron's latest subvariants. The US biotech company announced earlier this month that the so-called "bivalent" vaccine, which targets the original Covid strain and original Omicron BA.1, performed better against both compared to its original Covid vaccine called Spikevax. In new results from a clinical study, the company said that the booster also did well against BA.4 and BA.5, Omicron's latest subvariants that are becoming dominant thanks to thei...
AFP
Washington (AFP) - US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron, and sees the shot as its "lead candidate" for a booster this fall. The so-called "bivalent" vaccine was tested in a trial of 814 adults and shown to produce 1.75 times more Omicron-specific neutralizing antibodies, which have the power to prevent infection, compared to Moderna's original Spikevax vaccine. All of the participants previously received three doses of Spikevax, and then slightly more than half went on to get a fourth dose o...
AFP
Washington (AFP) - US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron, and sees the shot as its "lead candidate" for a booster this fall. The so-called "bivalent" vaccine was tested in a trial of 814 adults and shown to produce 1.75 times more Omicron-specific neutralizing antibodies, which have the power to prevent infection, compared to Moderna's original Spikevax vaccine. All of the participants previously received three doses of Spikevax, and then slightly more than half went on to get a fourth dose o...
AFP
Washington (AFP) - US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years. Very young children are the only group that are yet to be eligible for the Covid-19 vaccine in the United States and in most countries, a source of concern for many parents. "We believe (this vaccine) will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against Covid-19 and will be especially welcomed by parents and caregivers," ...
AFP
Washington (AFP) - US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years. Children under six are the only age group that has yet to gain access to a Covid-19 vaccine in the United States and in most countries. "We believe (this vaccine) will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against Covid-19 and will be especially welcomed by parents and caregivers," the company's CEO Stephane Bancel sai...
AFP
Washington (AFP) - US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children under six years old after the two-shot regimen was found to be safe and produced a strong immune response. Specifically, two doses of 25 micrograms given to babies, toddlers and preschoolers generated similar levels of antibodies to two doses of 100 micrograms given to young people aged 18-25, indicating there would be similar levels of protection. Children under six are the only age group that has yet to gain access to a Covid-19 vaccine in the United States. Base...
AFP
Washington (AFP) - The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's Covid-19 "Spikevax" vaccine, which had previously received an emergency use authorization in the United States. "The public can be assured that Spikevax meets the FDA's high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States," acting FDA commissioner Janet Woodcock said in a statement. "The FDA's approval of Spikevax is a significant step in the fight against the Covid-19 pandemic, marking the secon...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら